Press release
Asia Pacific immunotherapy market is expecting a sound growth at a CAGR of 15.5% by 2023
Asia Pacific Cancer Immunotherapy Market Research Report: By Type of Therapy (Monoclonal Antibodies, Cancer Vaccines, Immunomodulators and others), By Application (Lung Cancer, Blood Cancer, Melanoma, Breast Cancer and others), and By End User (Hospitals and Clinics, Research Laboratories, Cancer Institute) - Forecasted till 2023
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/639
Segmentation
Asia Pacific cancer immunotherapy market is segmented
On the basis of type of therapy, application, and end users.
On the basis of type of therapy, the market is segmented into monoclonal antibodies, cancer vaccines, immunomodulators and other.
On the basis of application the market is segmented as lung cancer, blood cancer, melanoma, breast cancer, and other.
On the basis of end user, the market is segmented into hospitals & clinics, research laboratories, cancer institute, and others.
Market Scenario:
Cancer is condition of uncontrolled cell growth. It is one of the deadliest disease in the world and the second major cause of deaths across the globe. It is an abnormal cell growth with the potential to spread to other part of the body. Over 100 types of cancer has been registered that had affected human so far. According to a survey carried out by Pfizer, in 2012, 6.7 million of cancer cases was registered in Asia Pacific region, which is expected to increase continuously. Due to deteriorating lifestyle, smoking, and alcoholism, the prevalence of cancer is increasing. Increasing cancer population is the major reason for the increasing growth of the Asia Pacific immunotherapy market. Different treatment are available in the market but the advantage of immunotherapy is high as compared to other available therapies. It is mostly effective against melanoma cancer where chemotherapy and other radiation therapy fails. Increasing government support for research & development and increasing healthcare expenditure have fuelled the market growth, over the last few years. However, high side effect of the treatments and cost of the therapy may slow the market growth during the forecasted period.
Asia Pacific immunotherapy market is expecting a sound growth at a CAGR of 15.5% during the forecasted period 2017-2023.
Get more information of Reports @ https://www.marketresearchfuture.com/enquiry/639
Key Players
The key players for the market:
Amgen Inc. (US)
Bristol-Myers Squibb Company (US)
Eli Lilly and Company (US)
AstraZeneca Plc. (UK)
GlaxoSmithKline Plc. (UK)
Bayer AG (Germany)
Hoffmann-La Roche Ltd. (Switzerland)
Pfizer, Inc. (US)
Merck & Co., Inc. (US)
Novartis AG (Switzerland)
Spectrum Pharmaceuticals Inc. (US)
Janssen Biotech, Inc. (US)
Sanofi (France), AbbVie Inc. (US)
Takeda Pharmaceuticals (Japan)
Oncomed Pharmaceuticals (US)
Immunomedics (US)
Browse Full Report @ https://www.marketresearchfuture.com/reports/asia-pacific-cancer-immunotherapy-market
Table Of Contents
1 Report Prologue
2 Market Introduction
3 Research Methodology
4 Market Dynamics
5 Market Factor Analysis
8. Asia Pacific Cancer Immunotherapy Market, By End User
9. Asia Pacific Cancer Immunotherapy Market, By Region
10. Competitive Landscape
11 Company Profile
12 Conclusion
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for North America, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions
Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia Pacific immunotherapy market is expecting a sound growth at a CAGR of 15.5% by 2023 here
News-ID: 801298 • Views: …
More Releases from Market Research Future
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years.
Market Overview and Size
The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in…
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends.
Get Sample @ https://www.marketresearchfuture.com/sample_request/41217
Market Size and Growth
The global washable…
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and…
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview:
The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical…
More Releases for Asia
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,…
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022.
23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property…
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019".
The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn…
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia
Equipping Asia’s navies with the latest diving technology for asymmetric warfare and
operations
SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is
seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting…
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients.
Asked to comment on the move, Luke Palmer, the…
